Loading company…
Ranok Therapeutics develops cancer treatments using its chaperone-mediated protein degradation technology.
Founded in 2018, Ranok Therapeutics researches and develops cancer drugs and is based in Hangzhou, China. Its CHAMP technology uses chaperone-mediated protein degradation to target proteins, including targets in tumor tissue. The company was founded by CEO Weiwen Ying, whose experience includes medicinal chemistry and drug development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in